BDBM50528194 CHEMBL4517408
SMILES COc1cc(cc(OC)c1OC)-c1cncc(c1C)-c1ccc(cc1)N1CCNCC1
InChI Key InChIKey=RKBYYWVZFBATHQ-UHFFFAOYSA-N
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 36 hits for monomerid = 50528194
Affinity DataIC50: 13nMAssay Description:Inhibition of human ALK2 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assayMore data for this Ligand-Target Pair
3D Structure (crystal)TargetTRAF2 and NCK-interacting protein kinase(Homo sapiens (Human))
Ontario Institute for Cancer Research
Curated by ChEMBL
Ontario Institute for Cancer Research
Curated by ChEMBL
Affinity DataIC50: 96nMAssay Description:Inhibition of TNIK (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 13nMAssay Description:Inhibition of human ALK2 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assayMore data for this Ligand-Target Pair
Affinity DataIC50: 8nMAssay Description:Inhibition of ALK2 G328V mutant (unknown origin) by radiometric assayMore data for this Ligand-Target Pair
Affinity DataIC50: 9nMAssay Description:Inhibition of human ALK2 R206H mutant using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assayMore data for this Ligand-Target Pair
Affinity DataIC50: 13nMAssay Description:Inhibition of ALK2 R258G mutant (unknown origin) by radiometric hotspot assayMore data for this Ligand-Target Pair
Affinity DataIC50: 45nMAssay Description:Competitive displacement of PBI-6908 from nanoluciferase-fused ALK2 (unknown origin) expressed in HEK293 cells incubated for 2 hrs by NanoBRET NanoGl...More data for this Ligand-Target Pair
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Ontario Institute for Cancer Research
Curated by ChEMBL
Ontario Institute for Cancer Research
Curated by ChEMBL
Affinity DataIC50: 2.71E+3nMAssay Description:Inhibition of recombinant human ALK5 expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter after 24 hrs by dual ...More data for this Ligand-Target Pair
Affinity DataIC50: 6nMAssay Description:Competitive displacement of PBI-6908 from nanoluciferase-fused ALK2 G328V mutant (unknown origin) expressed in HEK293 cells incubated for 2 hrs by Na...More data for this Ligand-Target Pair
Affinity DataIC50: 16nMAssay Description:Competitive displacement of PBI-6908 from nanoluciferase-fused ALK2 G356D mutant (unknown origin) expressed in HEK293 cells incubated for 2 hrs by Na...More data for this Ligand-Target Pair
Affinity DataIC50: 7nMAssay Description:Competitive displacement of PBI-6908 from nanoluciferase-fused ALK2 Q207D mutant (unknown origin) expressed in HEK293 cells incubated for 2 hrs by Na...More data for this Ligand-Target Pair
Affinity DataIC50: 12nMAssay Description:Competitive displacement of PBI-6908 from nanoluciferase-fused ALK2 R206H mutant (unknown origin) expressed in HEK293 cells incubated for 2 hrs by Na...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase receptor R3(Homo sapiens (Human))
Ontario Institute for Cancer Research
Curated by ChEMBL
Ontario Institute for Cancer Research
Curated by ChEMBL
Affinity DataIC50: 15nMAssay Description:Inhibition of human ALK1 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assayMore data for this Ligand-Target Pair
TargetBone morphogenetic protein receptor type-1A(Homo sapiens (Human))
Ontario Institute for Cancer Research
Curated by ChEMBL
Ontario Institute for Cancer Research
Curated by ChEMBL
Affinity DataIC50: 428nMAssay Description:Inhibition of human ALK3 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assayMore data for this Ligand-Target Pair
TargetActivin receptor type-1B(Homo sapiens (Human))
Ontario Institute for Cancer Research
Curated by ChEMBL
Ontario Institute for Cancer Research
Curated by ChEMBL
Affinity DataIC50: 1.34E+3nMAssay Description:Inhibition of human ALK4 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assayMore data for this Ligand-Target Pair
TargetBone morphogenetic protein receptor type-1B(Homo sapiens (Human))
Ontario Institute for Cancer Research
Curated by ChEMBL
Ontario Institute for Cancer Research
Curated by ChEMBL
Affinity DataIC50: 68nMAssay Description:Inhibition of human ALK6 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assayMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Ontario Institute for Cancer Research
Curated by ChEMBL
Ontario Institute for Cancer Research
Curated by ChEMBL
Affinity DataIC50: 336nMAssay Description:Inhibition of ABL1 (unknown origin)More data for this Ligand-Target Pair
TargetProtein-tyrosine kinase 6(Homo sapiens (Human))
Ontario Institute for Cancer Research
Curated by ChEMBL
Ontario Institute for Cancer Research
Curated by ChEMBL
Affinity DataIC50: 336nMAssay Description:Inhibition of BRK (unknown origin)More data for this Ligand-Target Pair
TargetEpithelial discoidin domain-containing receptor 1(Homo sapiens (Human))
Ontario Institute for Cancer Research
Curated by ChEMBL
Ontario Institute for Cancer Research
Curated by ChEMBL
Affinity DataIC50: 41nMAssay Description:Inhibition of DDR1 (unknown origin)More data for this Ligand-Target Pair
TargetMisshapen-like kinase 1(Homo sapiens (Human))
Ontario Institute for Cancer Research
Curated by ChEMBL
Ontario Institute for Cancer Research
Curated by ChEMBL
Affinity DataIC50: 336nMAssay Description:Inhibition of MINK (unknown origin)More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase NLK(Homo sapiens (Human))
Ontario Institute for Cancer Research
Curated by ChEMBL
Ontario Institute for Cancer Research
Curated by ChEMBL
Affinity DataIC50: 336nMAssay Description:Inhibition of NLK (unknown origin)More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase SIK2(Homo sapiens (Human))
Ontario Institute for Cancer Research
Curated by ChEMBL
Ontario Institute for Cancer Research
Curated by ChEMBL
Affinity DataIC50: 336nMAssay Description:Inhibition of SIK2 (unknown origin)More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase 20(Homo sapiens (Human))
Ontario Institute for Cancer Research
Curated by ChEMBL
Ontario Institute for Cancer Research
Curated by ChEMBL
Affinity DataIC50: 336nMAssay Description:Inhibition of ZAK (unknown origin)More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Homo sapiens (Human))
Ontario Institute for Cancer Research
Curated by ChEMBL
Ontario Institute for Cancer Research
Curated by ChEMBL
Affinity DataIC50: 1.72E+3nMAssay Description:Inhibition of recombinant human CB1 incubated for 60 mins by scintillation counting methodMore data for this Ligand-Target Pair
TargetAlpha-2A adrenergic receptor(Homo sapiens)
Ontario Institute for Cancer Research
Curated by ChEMBL
Ontario Institute for Cancer Research
Curated by ChEMBL
Affinity DataIC50: 2.18E+3nMAssay Description:Inhibition of recombinant human adrenergic alpha2A receptor incubated for 60 mins by scintillation counting methodMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Ontario Institute for Cancer Research
Curated by ChEMBL
Ontario Institute for Cancer Research
Curated by ChEMBL
Affinity DataIC50: 8.30E+3nMAssay Description:Inhibition of human ERG expressed in HEK293 cells after 5 mins by IonWorks barracuda patch clamp methodMore data for this Ligand-Target Pair
TargetCytochrome P450 1A2(Homo sapiens (Human))
Ontario Institute for Cancer Research
Curated by ChEMBL
Ontario Institute for Cancer Research
Curated by ChEMBL
Affinity DataIC50: >3.00E+4nMAssay Description:Inhibition of CYP1A2 in human liver microsomes using phenacetin as substrate incubated for 20 mins in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 2B6(Homo sapiens (Human))
Ontario Institute for Cancer Research
Curated by ChEMBL
Ontario Institute for Cancer Research
Curated by ChEMBL
Affinity DataIC50: >3.00E+4nMAssay Description:Inhibition of CYP2B6 in human liver microsomes using bupropion as substrate incubated for 20 mins in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 2C8(Homo sapiens (Human))
Ontario Institute for Cancer Research
Curated by ChEMBL
Ontario Institute for Cancer Research
Curated by ChEMBL
Affinity DataIC50: >3.00E+4nMAssay Description:Inhibition of CYP2C8 in human liver microsomes using paclitaxel as substrate incubated for 20 mins in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 2C9(Homo sapiens (Human))
Ontario Institute for Cancer Research
Curated by ChEMBL
Ontario Institute for Cancer Research
Curated by ChEMBL
Affinity DataIC50: >3.00E+4nMAssay Description:Inhibition of CYP2C9 in human liver microsomes using tolbutamide as substrate incubated for 20 mins in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 2C19(Homo sapiens (Human))
Ontario Institute for Cancer Research
Curated by ChEMBL
Ontario Institute for Cancer Research
Curated by ChEMBL
Affinity DataIC50: >3.00E+4nMAssay Description:Inhibition of CYP2C19 in human liver microsomes using mephenytoin as substrate incubated for 20 mins in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 2D6(Homo sapiens (Human))
Ontario Institute for Cancer Research
Curated by ChEMBL
Ontario Institute for Cancer Research
Curated by ChEMBL
Affinity DataIC50: >3.00E+4nMAssay Description:Inhibition of CYP2D6 in human liver microsomes using dextromethorphan as substrate incubated for 20 mins in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 3A4(Homo sapiens (Human))
Ontario Institute for Cancer Research
Curated by ChEMBL
Ontario Institute for Cancer Research
Curated by ChEMBL
Affinity DataIC50: >3.00E+4nMAssay Description:Inhibition of CYP3A4 in human liver microsomes using midazolam as substrate incubated for 5 mins in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 3A4(Homo sapiens (Human))
Ontario Institute for Cancer Research
Curated by ChEMBL
Ontario Institute for Cancer Research
Curated by ChEMBL
Affinity DataIC50: >9.00E+3nMAssay Description:Inhibition of CYP3A4 in human liver microsomes using testosterone as substrate incubated for 10 mins in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Ontario Institute for Cancer Research
Curated by ChEMBL
Ontario Institute for Cancer Research
Curated by ChEMBL
Affinity DataIC50: 2.43E+3nMAssay Description:Inhibition of human ALK5 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assayMore data for this Ligand-Target Pair
TargetTGF-beta receptor type-1(Homo sapiens (Human))
Ontario Institute for Cancer Research
Curated by ChEMBL
Ontario Institute for Cancer Research
Curated by ChEMBL
Affinity DataIC50: 1.83E+3nMAssay Description:Inhibition of human ALK5 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assayMore data for this Ligand-Target Pair